MedPath

The Effect of rose damascene oil and sesame oil on the prevention of striae gravidarum

Phase 3
Conditions
Pregnancy striae.
Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Registration Number
IRCT20131009014957N9
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
150
Inclusion Criteria

Gestational age of 16-20 weeks
Having a single live fetus
Nulliparity
Being at the age of 18-35 years
Body mass index of 18.5-25 kg /m2
Being literate (at least writing and reading skills)

Exclusion Criteria

The use of other herbal or chemical drugs on the affected area
Sensitivity to rose oil and sesame oil and not being able to use the drug twice daily
Taking corticosteroids
previous striae
Surgical scar on the abdomen
Having chronic diseases
Having adrenal glands diseases
Presence of skin disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence rate of gestational striae. Timepoint: Evaluation of incidence in 35-37 weeks of gestation. Method of measurement: Davey method.;Incidence rate of itching. Timepoint: The incidence of pruritus in 35-37 weeks of gestation. Method of measurement: Kamini method.;Severity of gestational striae. Timepoint: Evaluation of severity of striae in 35-37 weeks of gestation. Method of measurement: Davey method.;Severity of itching. Timepoint: Evaluation of severity of pruritus in 35-37 weeks of gestation. Method of measurement: Kamini method.
Secondary Outcome Measures
NameTimeMethod
Satisfaction of medication use. Timepoint: 35-38 weeks of gestation. Method of measurement: Satisfaction Questionnaire.;Side effects. Timepoint: 35-38 weeks of gestation. Method of measurement: Side effects Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath